ADVFN - ニュース

S&P 500

5,267.84

-0.74%

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STEL	Stellar Bancorp Inc
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CINGW	Cingulate Inc
2024/05/24	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:WEAV	Weave Communications Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:CRM	Salesforce Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MCK	McKesson Corporation
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:KNTK	Kinetik Holdings Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AGYS	Agilysys Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:YUMC	Yum China Holdings Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MEDS	TRxADE HEALTH Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EQ	Equillium Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ABVC	ABVC BioPharma Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RZC	Reinsurance Group of America Incorporated
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:LILMW	Lilium NV
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:EOG	EOG Resources Inc
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:FMSTW	Foremost Lithium Resource and Technology Ltd
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:LEGN	Legend Biotech Corporation
2024/05/24	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CURIW	CuriosityStream Inc
2024/05/24	06 : 00	Business Wire	Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:GMAB	Genmab AS
2024/05/24	06 : 00	Business Wire	Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
2024/05/24	06 : 00	GlobeNewswire Inc.	IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting	NASDAQ:INAB	IN8bio Inc
2024/05/24	06 : 00	Business Wire	Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA	NASDAQ:LEGN	Legend Biotech Corporation
2024/05/24	06 : 00	Business Wire	SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual Meeting	NASDAQ:CADL	Candel Therapeutics Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual Meeting	TG:2GH	Merus NV
2024/05/24	06 : 00	GlobeNewswire Inc.	Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:BPTH	Bio Path Holdings Inc
2024/05/24	06 : 00	GlobeNewswire Inc.	Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024	NASDAQ:EVAX	Evaxion Biotech AS
2024/05/24	06 : 00	Business Wire	Obsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
2024/05/24	06 : 00	GlobeNewswire Inc.	Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting	NASDAQ:MURA	Mural Oncology PLC
2024/05/24	06 : 00	Business Wire	Dentalcorp Announces Annual General Meeting Voting Results	TSX:DNTL	dentalcorp Holdings Ltd
2024/05/24	06 : 00	GlobeNewswire Inc.	Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024